Federal award (DEFINITIVE CONTRACT, fiscal year 2022)
Recipient: NUVOX PHARMA, L.L.C.
Awarding agency: Department of Health and Human Services / Office of Assistant Secretary for Preparedness and Response
Funding agency: Department of Health and Human Services / Office of Assistant Secretary for Preparedness and Response
Period of performance: 2023-07-28 to 2025-01-28
Current total value of award: $749447.48
Description: RESEARCH AND DEVELOPMENT - AOI #19 FOR THE DEVELOPMENT OF NOVEL OXYGEN THERAPEUTIC NAN02 FOR COVID19: EXTEND